Zosano Pharma Raises $30 Million
Zosano Pharma Inc. has raised $30 million in Series B funding. Nomura Phase4 Ventures led the round, and was joined by return backers New Enterprise Associates, Nomura Phase4 Ventures, HBM BioVentures and ProQuest Investments. The Fremont, Calif.-based company was founded in 2006 as a Johnson & Johnson Internal Ventures spinout from the ALZA Co., to work on several product opportunities based on the company's transdermal microprojection delivery system. It previously raised a $90 million Series A round.
8 July 2009•3 mins read
